Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 9, 2018

Total Value ($000): $466,864 (100.0% shares, 0.0% debt)

Holdings (30)

ASND Ascendis Pharma 15.2%

Value ($000) $70,779 Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd 11.4%

Value ($000) $53,335 Shares 1,976,818 Est. Cost $37.38 Unrealized —

ACRS Aclaris Therapeutics 8.7%

Value ($000) $40,620 Shares 1,647,214 Est. Cost $19.11 Unrealized +27.4%

APLS Apellis Pharmaceuticals, Inc. 6.8%

Value ($000) $31,635 Shares 1,457,834 Est. Cost $14.72 Unrealized 0.0%

CDXS Codexis, Inc. 5.5%

Value ($000) $25,508 Shares 3,054,825 Est. Cost $3.85 Unrealized +79.5%

— Eiger BioPharmaceuticals 5.4%

Value ($000) $24,988 Shares 1,791,257 Est. Cost $16.42 Unrealized —

— Nabriva Therapeutics Plc 5.2%

Value ($000) $24,364 Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Aimmune Therapeutics, Inc. 5.2%

Value ($000) $24,342 Shares 643,626 Est. Cost $10.99 Unrealized —

— Kala Pharmaceuticals, Inc. 4.6%

Value ($000) $21,428 Shares 1,158,911 Est. Cost $22.84 Unrealized —

— Advanced Accelerator Applications S.A. 4.4%

Value ($000) $20,343 Shares 249,241 Est. Cost $35.30 Unrealized —

— Strongbridge Biopharma Plc 3.8%

Value ($000) $17,780 Shares 2,452,397 Est. Cost $2.40 Unrealized —

— Verona Pharma Plc 3.8%

Value ($000) $17,723 Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Kadmon Holdings, Inc. 2.6%

Value ($000) $12,067 Shares 3,333,333 Est. Cost $3.35 Unrealized —

— Selecta Biosciences, Inc. 2.4%

Value ($000) $10,979 Shares 1,119,189 Est. Cost $19.86 Unrealized —

— Amyris, Inc. 2.3%

Value ($000) $10,600 Shares 2,826,711 Est. Cost $3.20 Unrealized —

— Sierra Oncology, Inc 1.9%

Value ($000) $9,095 Shares 2,438,270 Est. Cost $1.55 Unrealized —

— Soleno Therapeutics, Inc. 1.6%

Value ($000) $7,260 Shares 4,033,534 Est. Cost $1.80 Unrealized —

ZLAB Zai Lab LTD 1.4%

Value ($000) $6,742 Shares 317,567 Est. Cost $27.00 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.2%

Value ($000) $5,496 Shares 1,213,290 Est. Cost $5.62 Unrealized -1.2%

RGNX Regenxbio Inc. 1.2%

Value ($000) $5,466 Shares 164,403 Est. Cost $12.80 Unrealized +135.4%

— Foamix Pharmaceuticals Ltd. 1.1%

Value ($000) $5,139 Shares 855,000 Est. Cost $9.26 Unrealized —

— Zogenix, Inc. 0.9%

Value ($000) $4,205 Shares 105,000 Est. Cost $40.05 Unrealized —

— Agile Therapeutics, Inc. 0.9%

Value ($000) $4,073 Shares 1,513,975 Est. Cost $6.21 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.6%

Value ($000) $2,928 Shares 300,325 Est. Cost $7.13 Unrealized +46.0%

— Trevena, Inc. 0.6%

Value ($000) $2,765 Shares 1,728,000 Est. Cost $7.67 Unrealized —

CRSP CRISPR Therapeutics AG 0.5%

Value ($000) $2,313 Shares 98,511 Est. Cost $18.69 Unrealized +1.7%

— Sunesis Pharmaceuticals, Inc. 0.4%

Value ($000) $1,845 Shares 500,000 Est. Cost $3.62 Unrealized —

— BioPharmX Corporation 0.3%

Value ($000) $1,521 Shares 13,799,944 Est. Cost $0.38 Unrealized —

— Akari Therapeutics Plc 0.3%

Value ($000) $1,498 Shares 345,850 Est. Cost $14.00 Unrealized —

— Soleno Therapeutics, Inc. 0.0%

Value ($000) $27 Shares 188,772 Est. Cost $0.14 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ASND	Ascendis Pharma	1,766,832	$70,779	15.2%	$17.51	—	ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd	1,976,818	$53,335	11.4%	$37.38	—	Common	G11196105
ACRS	Aclaris Therapeutics	1,647,214	$40,620	8.7%	$19.11	+27.4%	Common	00461U105
APLS	Apellis Pharmaceuticals, Inc.	1,457,834	$31,635	6.8%	$14.72	0.0%	Common	03753U106
CDXS	Codexis, Inc.	3,054,825	$25,508	5.5%	$3.85	+79.5%	Common	192005106
—	Eiger BioPharmaceuticals	1,791,257	$24,988	5.4%	$16.42	—	Common	28249U105
—	Nabriva Therapeutics Plc	4,074,190	$24,364	5.2%	$8.19	—	SHS	G63637105
—	Aimmune Therapeutics, Inc.	643,626	$24,342	5.2%	$10.99	—	Common	00900T107
—	Kala Pharmaceuticals, Inc.	1,158,911	$21,428	4.6%	$22.84	—	Common	483119103
—	Advanced Accelerator Applications S.A.	249,241	$20,343	4.4%	$35.30	—	ADS	00790T100
—	Strongbridge Biopharma Plc	2,452,397	$17,780	3.8%	$2.40	—	Ordinary Shares	G85347105
—	Verona Pharma Plc	1,492,951	$17,723	3.8%	$13.61	—	ADS	925050106
—	Kadmon Holdings, Inc.	3,333,333	$12,067	2.6%	$3.35	—	Common	48283N106
—	Selecta Biosciences, Inc.	1,119,189	$10,979	2.4%	$19.86	—	Common	816212104
—	Amyris, Inc.	2,826,711	$10,600	2.3%	$3.20	—	Common	03236M200
—	Sierra Oncology, Inc	2,438,270	$9,095	1.9%	$1.55	—	Common	82640U107
—	Soleno Therapeutics, Inc.	4,033,534	$7,260	1.6%	$1.80	—	Common	834203200
ZLAB	Zai Lab LTD	317,567	$6,742	1.4%	$27.00	—	ADR	98887Q104
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$5,496	1.2%	$5.62	-1.2%	Common	05156V102
RGNX	Regenxbio Inc.	164,403	$5,466	1.2%	$12.80	+135.4%	Common	75901B107
—	Foamix Pharmaceuticals Ltd.	855,000	$5,139	1.1%	$9.26	—	SHS	M46135105
—	Zogenix, Inc.	105,000	$4,205	0.9%	$40.05	—	Common	98978L204
—	Agile Therapeutics, Inc.	1,513,975	$4,073	0.9%	$6.21	—	Common	00847L100
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2,928	0.6%	$7.13	+46.0%	Common	483497103
—	Trevena, Inc.	1,728,000	$2,765	0.6%	$7.67	—	Common	89532E109
CRSP	CRISPR Therapeutics AG	98,511	$2,313	0.5%	$18.69	+1.7%	NAMEN AKT	H17182108
—	Sunesis Pharmaceuticals, Inc.	500,000	$1,845	0.4%	$3.62	—	Common Par	867328700
—	BioPharmX Corporation	13,799,944	$1,521	0.3%	$0.38	—	Common	09072X101
—	Akari Therapeutics Plc	345,850	$1,498	0.3%	$14.00	—	ADR	00972G108
—	Soleno Therapeutics, Inc.	188,772	$27	0.0%	$0.14	—	Warrant	834203135